Search

Your search keyword '"de Visser, Karin E."' showing total 362 results

Search Constraints

Start Over You searched for: Author "de Visser, Karin E." Remove constraint Author: "de Visser, Karin E."
362 results on '"de Visser, Karin E."'

Search Results

1. Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

2. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

5. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer

6. Immunoediting instructs tumor metabolic reprogramming to support immune evasion

7. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk

9. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

12. Abstract A052: Dissecting the immune regulatory mechanisms of distinct PI3K alterations in invasive lobular carcinoma

14. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer

17. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells

19. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

20. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

23. Supplementary Tables 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

24. Data from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

25. Supplementary Figures 1 from Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

26. Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

27. A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the Proliferation, Immune response and RNA splicing modules in breast cancer

33. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer:the GELATO trial

34. Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors

46. Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Catalog

Books, media, physical & digital resources